Aesthetic Medical International Holdings Group (PAIYY)
OTHER OTC:PAIYY
Want to see PAIYY full AI Analyst Report?
Top Page
Aesthetic Medical International Holdings Group
(OTC:PAIYY)
Select Model
Select Model
Rating:39Underperform
Price Target:
$0.08
▼(-73.45% Downside)
Action:Reiterated
Date:06/06/26
The score is driven primarily by weak financial performance—widening losses, a swing to negative cash flow, higher debt, and negative equity—which creates elevated balance-sheet and funding risk. Technical indicators provide only limited offset, and valuation metrics offer little support due to ongoing losses and no dividend data.
Positive Factors
Gross margin resilience
Mid‑40% to low‑50% gross margins indicate structurally strong unit economics and pricing power in product/service mix. That margin buffer supports recovery potential: if SG&A and R&D are controlled, scaled revenue can more readily convert into sustainable operating profits over the medium term.
Negative Factors
Negative equity and rising leverage
Negative shareholders' equity and materially higher debt materially reduce financial flexibility and increase insolvency risk. With limited equity cushion, the firm is more dependent on external financing and faces higher refinancing and covenant risks, constraining strategic choices over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross margin resilience
Mid‑40% to low‑50% gross margins indicate structurally strong unit economics and pricing power in product/service mix. That margin buffer supports recovery potential: if SG&A and R&D are controlled, scaled revenue can more readily convert into sustainable operating profits over the medium term.
Read all positive factors
Aesthetic Medical International Holdings Group (PAIYY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.94M
Dividend YieldN/A
Average Volume (3M)576.00
Price to Earnings (P/E)―
Beta (1Y)-1.68
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees1,286
SectorHealthcare
Sector Strength45
IndustryMedical - Equipment & Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding48,687,584
10 Day Avg. Volume50
30 Day Avg. Volume576
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.90
Price to Sales (P/S)0.03
P/FCF Ratio-0.80
Enterprise Value/Market Cap59.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aesthetic Medical International Holdings Group Business Overview & Revenue Model
Company Description
Aesthetic Medical International Holdings Group Limited is a healthcare provider specializing in aesthetic medical services, operating in both the People's Republic of China and Singapore. The company's offerings encompass a range of surgical aesth...
How the Company Makes Money
null...
Aesthetic Medical International Holdings Group Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
18
Very Negative
Cash Flow
27
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 703.16M | 755.67M | 682.59M | 670.09M | 645.59M |
| Gross Profit | 325.14M | 337.79M | 322.05M | 355.59M | 269.50M |
| EBITDA | 62.38M | 73.33M | 25.31M | -11.05M | -554.95M |
| Net Income | -51.89M | -19.95M | -37.43M | -76.25M | -586.62M |
Balance Sheet | |||||
| Total Assets | 511.22M | 486.22M | 560.66M | 546.37M | 576.94M |
| Cash, Cash Equivalents and Short-Term Investments | 65.40M | 42.84M | 62.34M | 12.16M | 39.29M |
| Total Debt | 280.76M | 179.30M | 244.55M | 393.10M | 405.91M |
| Total Liabilities | 554.48M | 476.88M | 527.03M | 672.25M | 763.36M |
| Stockholders Equity | -20.61M | 30.46M | 48.89M | -113.66M | -156.67M |
Cash Flow | |||||
| Free Cash Flow | -23.01M | 48.88M | 18.83M | -76.80M | 17.65M |
| Operating Cash Flow | -16.29M | 79.67M | 74.29M | -75.13M | 51.09M |
| Investing Cash Flow | -405.63K | -30.32M | -52.25M | 3.11M | -11.53M |
| Financing Cash Flow | 37.62M | -68.55M | 29.06M | 45.55M | -45.23M |
Aesthetic Medical International Holdings Group Technical Analysis
Negative
0.29
Price Trends
0.06
Negative
0.05
Negative
0.11
Negative
Market Momentum
-0.01
Negative
33.89
Neutral
-14.81
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PAIYY, the sentiment is Negative. The current price of 0.29 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.06, and above the 200-day MA of 0.11, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 33.89 is Neutral, neither overbought nor oversold. The STOCH value of -14.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PAIYY.
Aesthetic Medical International Holdings Group Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | $8.53M | -0.18 | -253.43% | ― | ― | 97.61% | |
42 Neutral | $1.61M | -0.01 | -164.27% | ― | -7.16% | 71.12% | |
40 Underperform | $5.86M | -0.69 | -220.42% | ― | ― | 51.71% | |
39 Underperform | $3.94M | -0.03 | -76.57% | ― | ― | ― |
* Healthcare Sector Average
PAIYY
Aesthetic Medical International Holdings Group
0.08
-0.10
-55.00%
NCNA
Nucana
2.05
-13.19
-86.55%
CELZ
Creative Medical Technology Holdings
2.17
-0.28
-11.47%
HSCS
Heart Test Laboratories, Inc.
1.84
-1.69
-47.88%
TNMG
TNL Mediagene
0.63
-9.84
-93.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.